New Generation DDAs

Six drugs promise to further revolutionize HCV treatments by Larry Buhl The hepatitis C (HCV) treatment revolution is a little more than a year old, but...

Don’t Fear the Treatment

HCV advocate, author & nurse Lucinda Porter offers perspectives on care by Larry Buhl Lucinda Porter, RN, understands viral hepatitis from both sides: as a healthcare practitioner and...

Homeless at Risk

HCV funding and support for vulnerable populations lag far behind HIV by Larry Buhl A study published in the July/August 2012 issue of Public Health Reports...

Greatest Generation

CDC Recommends Hepatitis C Testing for All Boomers by Larry Buhl For years CDC guidelines called for hepatitis C (HCV) testing when someone has known risk factors,...

Smart Body Art

Do tattoos & piercings carry an increased HCV risk? by Larry Buhl In the U.S., an estimated thirty-six percent of people under thirty have tattoos, according...

Drug+Drug

HIV/HCV drug interaction updates from CROI by Larry Buhl Several panels from CROI 2012 showed drug-drug interactions between new direct-acting antiviral agents for hepatitis C (HCV) and...

Direct Acting Antiretrovirals

Awareness Is Key What You Need to Know About the Side Effect Profiles of New HCV Antiretrovirals by Larry Buhl By all accounts, adding the new direct-acting...

Blocking the Entrance

Entry inhibitors usher in a new phase of hep C research by Larry Buhl Future therapy for hepatitis C infection may include a variety of drugs...

Taking a Toll

LifeGuide Hep C is surpassing HIV as a deadlier disease by Larry Buhl There was a new milestone reached last month when a new study suggested...

Right Around the Corner

New meds offer hope for interferon-free regimen by Larry Buhl LifeGuide In the past year several protease inhibitors were introduced for chronic hepatitis C, marking a...

LATEST POSTS

An Aspirin A Day May Keep HIV Away

The Journal of the International AIDS Society (JIAS) has published the results of a study conducted by researchers from the universities of Manitoba, Waterloo...

Pride In Spite of It All

Let’s Talk About PrEP